Biorbyt
Biorbyt is a Cambridge, UK-based life science reagents manufacturer and supplier offering over 500,000 antibodies, proteins, ELISA kits, and molecular biology products, plus custom antibody and protein services, to academic, commercial, and clinical researchers worldwide.
- Company typePrivate
- Founded2011
- HeadquartersCambridge, United Kingdom
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What Biorbyt does
Biorbyt is a privately held life science reagents manufacturer and supplier headquartered in Cambridge, United Kingdom, with additional offices in Durham, North Carolina (US) and Wuhan (China). Founded in 2011, the company offers a catalog of more than 500,000 products spanning primary and secondary antibodies, recombinant and native proteins, ELISA kits, small molecules, and molecular biology reagents (PCR, qPCR, nucleic acid isolation). Its core technology is a validated reagents platform with data-backed quality control published in peer-reviewed research, complemented by custom development services including antibody engineering, custom monoclonal, polyclonal, recombinant and nanobody antibody production, recombinant protein expression in E. coli, HEK293, and yeast systems, antibody conjugation, and peptide synthesis.
The company serves academic, commercial, and clinical life science researchers, plus veterinary and plant-research specialists, operating a direct-to-consumer e-commerce storefront on biorbyt.com supported by bulk-enquiry enterprise sales and a global distributor network. Revenue is generated through one-time catalog sales with tiered unit pricing (antibodies $50–$610, ELISA kits $300–$7,430) and professional-services fees for custom reagent development. Marketing relies on scientific content marketing, a peer-reviewed literature citation platform (3,727 publications referencing Biorbyt products), promotional campaigns, and lab-credit loyalty programs. The business holds ISO 9001 certification and received the UK Queen’s Award for Enterprise (International Trade) in 2021, and has cumulatively delivered over 1,000,000 bio-reagents to researchers worldwide. Leadership consists of co-founders Tillmann Ziegert (CEO) and Qun Yang (COO); no institutional investors, funding rounds, or M&A activity are disclosed.
Biorbyt firmographics
Firmographics- Name
- Biorbyt
- Legal name
- Biorbyt Ltd.
- Website
- https://biorbyt.com
- Company type
- Private
- Founded year
- 2011
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- Biorbyt is a Cambridge, UK-based life science reagents manufacturer and supplier offering over 500,000 antibodies, proteins, ELISA kits, and molecular biology products, plus custom antibody and protein services, to academic, commercial, and clinical researchers worldwide.
- Ownership category
- akta.pro rank
Biorbyt industry classification
Industry- Product category
- Life Science Reagents
- NAICS
- In-Vitro Diagnostic Substance Manufacturing (325413), Biological Product (except Diagnostic) Manufacturing (325414), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Biological Products, (No Disgnostic Substances) (2836), In Vitro & In Vivo Diagnostic Substances (2835), Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes) (HLAGAIAI)
- akta.pro secondary industries
- Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls) (HLAAAMAL), Antibody Discovery & Engineering Platforms (display tech, bispecifics, Fc engineering) (HLAAAIAB), Recombinant Protein Therapeutics (enzymes, hormones, growth factors) (HLAAAAAB), Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI), Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI)
Keywords
Where Biorbyt is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United Kingdom
- HQ region
- Europe
Offices3 records
Markets served
Biorbyt business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Operations, Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Infrastructure
Revenue model
- Standard Product Sales: One-time sales of catalog products including antibodies, proteins, ELISA kits, small molecules, and molecular biology reagents. Products are sold in various sizes with tiered pricing for bulk orders.
- Custom Services: Revenue from custom antibody development, recombinant protein expression, peptide synthesis, and other custom laboratory services tailored to specific customer research needs.
- Lab Credits and Promotions: Programs including citation grants ($100 credit for published papers citing products), validation credits ($50 for validation images), and review credits ($25 for product reviews) that drive customer loyalty and repeat purchases.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | ELISA Kit pricing by size |
| Unit Pricing | Pay-as-you-go | Antibody pricing by conjugation and size |
| Unit Pricing | Pay-as-you-go | Secondary antibody pricing |
| Unit Pricing | Pay-as-you-go | Conjugated antibody variants |
| Unit Pricing | Pay-as-you-go | Specialty fluorophore conjugates |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels8 records
Biorbyt product offering
Product offeringCore offering
Biorbyt manufactures and supplies life science research reagents, offering over 500,000 catalog products including primary and secondary antibodies, recombinant and native proteins, ELISA kits, small molecules (agonists, antagonists, inhibitors, toxins, antibiotics), and molecular biology tools (nucleic acid isolation, PCR/qPCR reagents). The company also delivers fee-for-service custom reagent development, including custom antibody engineering, recombinant protein expression, antibody conjugation, and peptide synthesis, serving academic, commercial, and clinical researchers globally.
Product overview
Biorbyt is a life science reagents company offering a comprehensive portfolio of over 500,000 products for research. Their core offerings include Primary Antibodies (Recombinant, Biosimilars, Isotype Controls, Bispecific, Epitope Tag, Phosphospecific), Secondary Antibodies (with various conjugates including FITC, HRP, Biotin), Proteins (Active, Recombinant, Native, Enzymes, Cytokines), ELISA Kits (Matched Pairs, Activity Assays, Competitive, Veterinary), Small Molecules (Agonists, Antagonists, Inhibitors), and Molecular Biology products (PCR, qPCR, Nucleic Acid Isolation). The company also provides extensive Custom Services including antibody engineering, recombinant protein expression, antibody conjugation, and peptide synthesis. Based in Cambridge, UK with offices in the US and China, Biorbyt serves life science researchers globally and maintains ISO 9001 certification.
Differentiator
Problem solved
Functional benefit
Products and services
- Primary Antibodies Catalog of primary antibodies covering recombinant, biosimilars, isotype controls (rabbit, mouse, rat), bispecific, epitope tag, phosphospecific, animal and veterinary, viral research, plant, and single domain antibodies for life science research applications.
- Secondary Antibodies Secondary antibody catalog including anti-rabbit (goat and mouse host), cross-adsorbed, anti-goat, anti-rat, anti-sheep, anti-mouse, anti-donkey, and anti-streptavidin, available with FITC, HRP, Biotin and other conjugates.
- Proteins Catalog proteins including active proteins, recombinant proteins expressed in E. coli, HEK293, yeast, and viral systems, native proteins, enzymes, protein ladders, cell lysates, and cytokines for research applications.
- ELISA Kits Enzyme-linked immunosorbent assay kits including matched pair, activity assay, and competitive ELISA kits, plus veterinary ELISA kits covering porcine, canine, bovine, and chicken (Gallus) species.
- Small Molecules Catalog of small molecule compounds including agonists, antagonists, inhibitors, toxins, antibiotics, and natural products for life science research applications.
- Molecular Biology Products Molecular biology reagents including DNA and RNA isolation kits, plasmid preparation, exosome isolation, PCR, qPCR, RT-PCR, Hoechst staining kit, DNA extraction, and RNA extraction tools.
- Custom Antibody Services Bespoke antibody development services including antibody engineering, custom rabbit monoclonal antibody, custom monoclonal antibodies, custom polyclonal antibodies, custom nanobody development, and custom recombinant antibodies for researchers requiring non-catalog reagents.
- Recombinant Protein Expression Services Custom protein expression services including recombinant protein production across E. coli, HEK293, yeast, and viral systems, plus full-length membrane and extracellular domain (ECD) protein expression for research projects.
- Antibody Conjugation Service Professional antibody conjugation service for adding labels, enzymes, fluorophores, biotin, gold, or other conjugates to customer-supplied or catalog antibodies for assay-specific needs.
- Custom Peptide Synthesis Custom peptide synthesis service for producing tailored peptides to customer-specified sequences for life science research applications.
Quantifiable outcome
- Over 1,000,000 bio-reagents delivered to life science researchers globally
- +1 more outcomes
Companies that use Biorbyt
Customer profileNamed customers1 record
Segments3 records
Ideal customer profiles3 records
Biorbyt technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
Biorbyt partnerships and signals
Strategic signalScale indicators5 records
Recent moves6 records
Expansion highlights5 records
Biorbyt competitors and assessment
Company assessmentDirect peers
- Abcam: Abcam is one of the world's largest primary antibody suppliers with a global catalog of 100,000+ antibodies, recombinant proteins, and assay kits. It directly competes with Biorbyt in catalog antibodies and ELISA kits sold to academic and commercial researchers worldwide; now owned by Danaher.
- Cell Signaling Technology: CST is a leading provider of antibodies and reagents focused on cell signaling research, with a deep proprietary catalog of primary antibodies and ELISA kits. It directly competes with Biorbyt in phospho-specific antibodies, ELISA kits, and validated reagents for cancer/neuroscience research.
- Bio-Techne: Bio-Techne (formerly Techne) is a major life science reagents and tools company owning R&D Systems, Novus Biologicals, Tocris, and ProteinSimple. It directly competes with Biorbyt across proteins (cytokines, recombinant proteins), antibodies, ELISA kits, and small molecules, with overlapping academic/biotech customer base.
- Proteintech Group: Proteintech is a privately held manufacturer of antibodies, proteins, and ELISA kits with a catalog of 200,000+ products. It is a direct peer to Biorbyt in catalog primary antibodies and ELISA kits, with similar go-to-market through direct e-commerce to academic and commercial researchers.
- GenScript: GenScript provides custom antibody services, recombinant protein expression, gene synthesis, and peptide synthesis — directly overlapping with Biorbyt's custom-services offering (antibody engineering, recombinant protein expression, peptide synthesis). It serves similar academic and biotech customers globally.
- Santa Cruz Biotechnology: Santa Cruz Biotechnology is a long-established supplier of research antibodies, CRISPR reagents, and lab products. It directly competes with Biorbyt in catalog primary and secondary antibodies across a wide range of research applications.
- Atlas Antibodies: Atlas Antibodies develops Triple A Polyclonal antibodies and PrecisA Monoclonals for academic and clinical research, with a strong focus on tissue-specific protein profiling. It competes directly with Biorbyt in catalog primary antibodies and protein research reagents.
- Rockland Immunochemicals: Rockland Immunochemicals manufactures antibodies and antibody-based tools including secondary antibodies, ELISA kits, and custom antibody services for research and diagnostic applications. It is a direct peer to Biorbyt in secondary antibodies, ELISA kits, and custom antibody development.
Broad incumbents
- Thermo Fisher Scientific: Thermo Fisher offers antibodies, ELISA kits, proteins, and reagents as part of its Life Sciences Solutions segment, alongside instruments and broader consumables. As a broad incumbent, it competes with Biorbyt across nearly every reagent category but through a much wider portfolio.
- Merck (MilliporeSigma): MilliporeSigma, the life science arm of Merck KGaA, supplies antibodies, ELISA kits, proteins, and small molecules for research as part of a much broader portfolio including chemicals and bioprocessing. It is a broad incumbent that competes with Biorbyt across catalog reagents.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat5 records
Key risks6 records
Key highlights7 records
Customer concentration
Biorbyt social profiles
Digital presenceBiorbyt compliance and trust
Trust signalCompliance2 records
Biorbyt financial estimates
Financial estimateRevenue estimate
Valuation estimate
Biorbyt leadership team
Management profileNumber of profiles
Profiles2 records
Biorbyt funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Biorbyt M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Biorbyt
What does Biorbyt do?
Biorbyt manufactures and supplies life science research reagents, offering over 500,000 catalog products including primary and secondary antibodies, recombinant and native proteins, ELISA kits, small molecules (agonists, antagonists, inhibitors, toxins, antibiotics), and molecular biology tools (nucleic acid isolation, PCR/qPCR reagents). The company also delivers fee-for-service custom reagent development, including custom antibody engineering, recombinant protein expression, antibody conjugation, and peptide synthesis, serving academic, commercial, and clinical researchers globally.
Is Biorbyt a public or private company?
Biorbyt is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Biorbyt founded?
Biorbyt was founded in 2011. It employs 11 to 50 people.
Where is Biorbyt based?
Biorbyt is headquartered in Cambridge, United Kingdom, in the Europe region.
How does Biorbyt make money?
Three revenue lines are on record. Standard Product Sales are the primary driver. The others are custom Services and lab Credits and Promotions.
Who are Biorbyt's main competitors?
Direct peers on record are Abcam, Cell Signaling Technology, Bio-Techne, Proteintech Group, GenScript, Santa Cruz Biotechnology, Atlas Antibodies and Rockland Immunochemicals. Broad incumbents are Thermo Fisher Scientific and Merck (MilliporeSigma).
Does Biorbyt have an API?
No public API is recorded for Biorbyt.
What industry is Biorbyt in?
Biorbyt's product category is Life Science Reagents. Its primary akta.pro industry code is HLAGAIAI, Reagents, Chemicals & Assay Kits (Buffers, Antibodies, ELISA, Enzymes), with a secondary code of HLAAAMAL, Biomarker Assay & Reagent Development (LDT/IVD assay design, antibodies/standards/controls). Its NAICS code is 325413 and its SIC code is 2836.